Drupal.behaviors.print = function(context) {window.print();window.close();}>
Alnylam Says USPTO Upholds Claims in Liver Cancer Drug Patent
March 15, 2012
Alnylam Says USPTO Upholds Claims in Liver Cancer Drug Patent
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
IP Update: Recent Patents, Patent Applications Awarded to Alnylam, Novartis, Tekmira, and More
May 23, 2013 / Gene Silencing News
IP Update: Recent Patents, Patent Applications Awarded to Alnylam, Tekmira, Opko, and More
July 26, 2012 / Gene Silencing News
IP Update: Recent Patents, Patent Applications Awarded to Alnylam, Merck, BASF, and More
April 18, 2013 / Gene Silencing News
IP Update: Recent Patents, Patent Applications Awarded to Alcon, Alnylam, Merck, and More
March 21, 2013 / Gene Silencing News
IP Update: Recent Patents, Patent Applications Awarded to OSU, City of Hope, Alnylam, and More
March 7, 2013 / Gene Silencing News